Literature DB >> 17409147

Therapy with minocycline aggravates experimental rabies in mice.

Alan C Jackson1, Courtney A Scott, James Owen, Simon C Weli, John P Rossiter.   

Abstract

Minocycline is a tetracycline derivative with antiapoptotic and anti-inflammatory properties, and the drug has been shown to have beneficial effects in a variety of models of neurological disorders. The potentially neuroprotective role of minocycline was assessed in experimental in vitro and in vivo models of rabies virus infection. In this study, 5 nM minocycline did not improve the viability of embryonic mouse cortical and hippocampal neurons infected in vitro with the attenuated SAD-D29 strain of rabies virus, based on assessments using trypan blue exclusion. Two-day-old ICR mice were inoculated in the right hind limb thigh muscle with SAD-D29, and they received daily subcutaneous injections of either 50 mg/kg minocycline or vehicle (phosphate-buffered saline). Infected minocycline-treated mice experienced an earlier onset of neurologic signs and greater mortality (83% versus 50%) than those receiving vehicle (log rank test, P=0.002 and P=0.003, respectively). Immunohistochemical analysis of rabies virus antigen distribution was performed at early time points and in moribund mice. There were greater numbers of infected neurons in the regional brain areas of minocycline-treated mice than in vehicle-treated mice, which was significant in the CA1 region of the hippocampus. There was less apoptosis (P=0.01) and caspase 3 immunostaining (P=0.0008) in the midbrains of mice treated with minocycline than in mice treated with vehicle, consistent with a neuroprotective role of neuronal apoptosis that may have had a mild effect of inhibiting viral spread. Reduced infiltration of CD3+ T cells was observed in the pons/medulla of moribund mice that received minocycline therapy (P=0.008), suggesting that the anti-inflammatory actions of minocycline may intensify the neurologic disease. These findings indicate that minocycline has important detrimental effects in the therapy of experimental rabies. Empirical therapy with minocycline should therefore be approached with caution in cases of human rabies and possibly other viral encephalitides until more experimental data become available.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409147      PMCID: PMC1900124          DOI: 10.1128/JVI.00323-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Comparative pathogenesis of recombinant rabies vaccine strain SAD-L16 and SAD-D29 with replacement of Arg333 in the glycoprotein after peripheral inoculation of neonatal mice: less neurovirulent strain is a stronger inducer of neuronal apoptosis.

Authors:  Alan C Jackson; Pamini Rasalingam; Simon C Weli
Journal:  Acta Neuropathol       Date:  2006-02-02       Impact factor: 17.088

2.  Rabies virus-induced apoptosis involves caspase-dependent and caspase-independent pathways.

Authors:  Luciana Sarmento; Tesfai Tseggai; Vikas Dhingra; Zhen F Fu
Journal:  Virus Res       Date:  2006-06-30       Impact factor: 3.303

Review 3.  The end of the (cell) line: methods for the study of apoptosis in vitro.

Authors:  A J McGahon; S J Martin; R P Bissonnette; A Mahboubi; Y Shi; R J Mogil; W K Nishioka; D R Green
Journal:  Methods Cell Biol       Date:  1995       Impact factor: 1.441

4.  Failure of therapeutic coma and ketamine for therapy of human rabies.

Authors:  Thiravat Hemachudha; Buncha Sunsaneewitayakul; Tayard Desudchit; Chusana Suankratay; Chanchai Sittipunt; Supaporn Wacharapluesadee; Pkamatz Khawplod; Henry Wilde; Alan C Jackson
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

Review 5.  Neuroprotective agents for clinical trials in ALS: a systematic assessment.

Authors:  B J Traynor; L Bruijn; R Conwit; F Beal; G O'Neill; S C Fagan; M E Cudkowicz
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

6.  Recombinant rabies virus vaccine strain SAD-l16 inoculated intracerebrally in young mice produces a severe encephalitis with extensive neuronal apoptosis.

Authors:  Pamini Rasalingam; John P Rossiter; Alan C Jackson
Journal:  Can J Vet Res       Date:  2005-04       Impact factor: 1.310

7.  Neuroprotective and anti-human immunodeficiency virus activity of minocycline.

Authors:  M Christine Zink; Jennifer Uhrlaub; Jesse DeWitt; Tauni Voelker; Brandon Bullock; Joseph Mankowski; Patrick Tarwater; Janice Clements; Sheila Barber
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

8.  Rabies virus infection of primary neuronal cultures and adult mice: failure to demonstrate evidence of excitotoxicity.

Authors:  Simon C Weli; Courtney A Scott; Christopher A Ward; Alan C Jackson
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

9.  Minocycline delays disease onset and mortality in reovirus encephalitis.

Authors:  Sarah M Richardson-Burns; Kenneth L Tyler
Journal:  Exp Neurol       Date:  2005-04       Impact factor: 5.330

10.  Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.

Authors:  K Morimoto; D C Hooper; S Spitsin; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  14 in total

1.  Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction.

Authors:  Jeffrey A Rumbaugh; Joseph Steiner; Ned Sacktor; Avindra Nath
Journal:  Futur HIV Ther       Date:  2008

2.  Epidemiological and clinical features of human rabies cases in Bali 2008-2010.

Authors:  Ni M Susilawathi; Agus E Darwinata; Ida B N P Dwija; Nyoman S Budayanti; Gusti A K Wirasandhi; Ketut Subrata; Ni K Susilarini; Raka A A Sudewi; Frank S Wignall; Gusti N K Mahardika
Journal:  BMC Infect Dis       Date:  2012-04-02       Impact factor: 3.090

Review 3.  Apoptosis in animal models of virus-induced disease.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

4.  Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice.

Authors:  Courtney A Scott; John P Rossiter; R David Andrew; Alan C Jackson
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

5.  Neuronal apoptosis does not play an important role in human rabies encephalitis.

Authors:  Alan C Jackson; Elizabeth Randle; Gail Lawrance; John P Rossiter
Journal:  J Neurovirol       Date:  2008-11-19       Impact factor: 2.643

6.  Cytoprotective activity of minocycline includes improvement of mitochondrial coupling: the importance of minocycline concentration and the presence of VDAC.

Authors:  Andonis Karachitos; Joaquin Jordan; Hanna Kmita
Journal:  J Bioenerg Biomembr       Date:  2012-05-11       Impact factor: 2.945

7.  Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1.

Authors:  Susan C Follstaedt; Sheila A Barber; M Christine Zink
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

8.  Reduced viral burden in paralytic compared to furious canine rabies is associated with prominent inflammation at the brainstem level.

Authors:  Shanop Shuangshoti; Nischol Thepa; Pornchai Phukpattaranont; Akanitt Jittmittraphap; Nirun Intarut; Veera Tepsumethanon; Supaporn Wacharapluesadee; Paul Scott Thorner; Thiravat Hemachudha
Journal:  BMC Vet Res       Date:  2013-02-14       Impact factor: 2.741

9.  Quantitative proteomics for identifying biomarkers for Rabies.

Authors:  Abhilash K Venugopal; S Sameer Kumar Ghantasala; Lakshmi Dhevi N Selvan; Anita Mahadevan; Santosh Renuse; Praveen Kumar; Harsh Pawar; Nandini A Sahasrabhuddhe; Mooriyath S Suja; Yarappa L Ramachandra; Thottethodi S Keshava Prasad; Shampur N Madhusudhana; Harsha Hc; Raghothama Chaerkady; Parthasarathy Satishchandra; Akhilesh Pandey; Susarla K Shankar
Journal:  Clin Proteomics       Date:  2013-03-22       Impact factor: 3.988

10.  Microglial Activation Promotes Cell Survival in Organotypic Cultures of Postnatal Mouse Retinal Explants.

Authors:  Rosa M Ferrer-Martín; David Martín-Oliva; Ana Sierra-Martín; Maria-Carmen Carrasco; María Martín-Estebané; Ruth Calvente; Sandra M Martín-Guerrero; José L Marín-Teva; Julio Navascués; Miguel A Cuadros
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.